ViewRay, Inc. (VRAYQ)

Market Cap	183.00
Revenue (ttm)	105.86M
Net Income (ttm)	-110.42M
Shares Out	183.40M
EPS (ttm)	-0.61
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,000
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	0.47
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About ViewRay

ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, Italy, France, Taiwan, the United Kingdom, and internationally. It provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers through a network ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 295
• Stock Exchange: OTCMKTS
• Ticker Symbol: VRAYQ

Financial Performance

In 2022, ViewRay's revenue was $102.21 million, an increase of 45.76% compared to the previous year's $70.12 million. Losses were -$107.33 million, -2.47% less than in 2021.